Killer Cell Immunoglobulin-like Receptors

Background

KIR is located on chromosome 19 (19q13.4) in the Leukocyte Receptor Complex (LRC). KIR is expressed on the surface of Natural Killer (NK) cells and some T cells. KIR do not undergo somatic rearrangement–a key difference from T-cell receptors. KIR interacts with HLA class I–their cognate ligand–to recognize and destroy unhealthy tissue cells while preventing the same from occurring to healthy cells. Therefore, NK cells play a role in fighting infections, resisting some cancers, pregnancy, and preventing autoimmunity. For further reading and references, I highly recommend the review article by Pollock, Harrison, and Norman on the immunogenetics and co-evolution of KIR and HLA class I.

KIR Locus

KIR Diversity

KIR diversity is influenced by gene content variation and sequence variation. Distinct DNA sequences of KIR genes are called “alleles.” Distinct polypeptide sequences of KIR genes are called “allotypes.” Because different DNA sequences of KIR gene can lead to the same polypeptide, there are more alleles than allotypes for a given KIR gene.

KIR Diversity Concept Definition
Gene Content Variation Presence/absence, fusion, duplication
Sequence Variation May alter ligand affinity or specificity, signal transduction ability, or surface expression (e.g., promoter activity, translation, intracellular trafficking)
Allele Distinct DNA sequence
Allotype Distinct polypeptide sequence

NK Cell Education

NK Cell Education
(i.e., Arming, Licensing)
Corresponding Pairs of KIR and HLA Class I Ligands Cytotoxicity and other Effector Abilities
Strong Many More
Weak Few Less

KIR Nomenclature

Inhibitory KIR

The main role of inhibitory KIR is to prevent cytotoxic NK and T cells from killing tissue cells–unless their HLA class I expression is lost or altered by infection or mutagenesis.

Activating KIR

Activating KIR help identify diseased cells for destruction by cytoxic NK and T cells. Binding of foreign peptides by HLA class I molecules retained by infected cells may be most critical for activating KIR.

Broad KIR Haplotypes

Broad KIR Haplotype KIR Copy Number Variation KIR Gene Organization Activating KIR
A Relatively stable Generally
non-variable
Less
B Extensive Highly variable More

KIR Ligand Motifs

Adapted from Pollock, Harrison, and Norman. JACI: In Practice. 2022.
KIR Ligand Motif HLA-A Allotypes HLA-B Allotypes HLA-C Allotypes
A3/A11 A*03, A*11

Bw4 A*23, A*24, A*32 B*07:27, B*08:02, B*08:03, (B13), B*15:13, B*15:16, B*15:17, B*15:23, B*15:24, B*15:36, B*15:43, B*15:67, B*27:01, B*27:02, B*27:03, B*27:04, B*27:05,
B*27:07, B*37, B*38, B*40:13, B*40:19, B*44, B*47, B*49, B*51, B*52, B*53, B*56:07, B*57, B*58, B*59

C1 C*01, C*03, C*07, C*08, C*12:02, C*12:03, C*12:06, C*12:08, C*13, C*14, C*16 B*46, B*73
C2 C*02, C*03:07, C*04, C*05, C*06, C*12:04, C*12:05, C*12:07, C*14:04, C*15, C*16:02, C*17, C*18

KIR3DL1 and KIR3DS1

Because of significant non-allelic recombination in the KIR region, the distinction between KIR genes and alleles can be confusing. Specifically, KIR3DL1 and KIR3DS1 are alleles of the same gene. Of the KIR3DS1 allotypes–3DS1013 and 014–are observed with the greatest frequency in any population.